/
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
Mentions
2 mentions · latest on 11 Oct 2026
See which tracked investors hold Alnylam Pharmaceuticals, Inc. →Ownership and position changes on OwnershipTrace